This department is offering the Clinical Sequencing Evidence-Generating Research (CSER2) – Clinical Sites (U01) grant to establish Clinical Sites aiming to define, generate, and analyze evidence on the clinical utility of genome sequencing. The research will focus on interactions affecting the implementation of clinical genome sequencing and overcoming barriers to integrating genomic data into healthcare systems. Applicants are required to recruit at least 25% of patients from diverse and underserved populations to contribute to a shared evidence base for clinical decision-making. The closing date for applications is September 7, 2016.
Opportunity ID: 283612
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-HG-16-010 |
| Funding Opportunity Title: | Clinical Sequencing Evidence-Generating Research (CSER2) – Clinical Sites (U01) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.172 — Human Genome Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | May 06, 2016 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Sep 07, 2016 |
| Current Closing Date for Applications: | Sep 07, 2016 |
| Archive Date: | Oct 08, 2016 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $2,000,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Public and State controlled institutions of higher education For profit organizations other than small businesses State governments County governments Independent school districts City or township governments Others (see text field entitled “Additional Information on Eligibility” for clarification) Special district governments Small businesses Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Funding Opportunity is to establish Clinical Sites that collectively encompass a broad spectrum of healthcare settings and serve ancestrally and socioeconomically diverse patients with a wide range of clinical conditions, to: 1) define, generate and analyze evidence regarding the clinical utility of genome sequencing; 2) research the critical interactions among patients, family members, health practitioners, and clinical laboratories that influence implementation of clinical genome sequencing; and 3) identify and address real-world barriers to integrating genomic, clinical, and healthcare utilization data within a healthcare system to build a shared evidence base for clinical decision-making. Applicants to this FOA are expected to recruit a minimum of 25% of patients who come from racial or ethnic minority populations, underserved populations, or populations who experience poorer medical outcomes. In contrast, applicants to the companion RFA HG-16-011 are expected to recruit a minimum of 60% of such patients. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-HG-16-010.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-D | Use for due dates on or after May 25, 2016 | PKG00223326 | Jul 05, 2016 | Sep 07, 2016 | View |
Package 1
Mandatory forms
283612 RR_SF424_2_0-2.0.pdf
283612 PHS398_CoverPageSupplement_3_0-3.0.pdf
283612 RR_OtherProjectInfo_1_3-1.3.pdf
283612 PerformanceSite_2_0-2.0.pdf
283612 RR_KeyPersonExpanded_2_0-2.0.pdf
283612 PHS398_ResearchPlan_3_0-3.0.pdf
Optional forms
283612 RR_Budget_1_3-1.3.pdf
283612 RR_SubawardBudget30_1_3-1.3.pdf
283612 PHS398_ModularBudget_1_2-1.2.pdf
283612 PHS_Inclusion_Enrollment_Report-1.0.pdf
283612 PHS_AssignmentRequestForm-1.0.pdf